Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Post by thisldu3on Aug 06, 2016 6:49pm

187 Views

Post# 25117093

RELAX AND BE HAPPY

Wondering when this stock should make some significant gains? Answer is simple. Just count the number of days since the private placement was completed. When Four months after the PP approaches the up switch will be turned on. Sit back and enjoy the ride, its starting soon for those of you that are challenged with counting.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features